These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23244816)

  • 1. Whole disease modeling to inform resource allocation decisions in cancer: a methodological framework.
    Tappenden P; Chilcott J; Brennan A; Squires H; Stevenson M
    Value Health; 2012 Dec; 15(8):1127-36. PubMed ID: 23244816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using whole disease modeling to inform resource allocation decisions: economic evaluation of a clinical guideline for colorectal cancer using a single model.
    Tappenden P; Chilcott J; Brennan A; Squires H; Glynne-Jones R; Tappenden J
    Value Health; 2013 Jun; 16(4):542-53. PubMed ID: 23796288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging trial and decision: a checklist to frame health technology assessments for resource allocation decisions.
    Grutters JP; Seferina SC; Tjan-Heijnen VC; van Kampen RJ; Goettsch WG; Joore MA
    Value Health; 2011; 14(5):777-84. PubMed ID: 21839418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economics and resourcing of complex healthcare systems.
    Baghbanian A; Torkfar G
    Aust Health Rev; 2012 Nov; 36(4):394-400. PubMed ID: 22958896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decision support through economic evaluation from the perspective of science in Germany].
    Graf von der Schulenburg JM
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):660-7. PubMed ID: 22526854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
    Al MJ; Feenstra T; Brouwer WB
    Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of economic evaluation results.
    Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S66-73. PubMed ID: 19253489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of decision analytic modeling in the health economic assessment of spinal intervention.
    Edwards NC; Skelly AC; Ziewacz JE; Cahill K; McGirt MJ
    Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S16-42. PubMed ID: 25299257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic issues in the development and use of practice guidelines: an application to resource allocation in dentistry.
    Birch S; Leake JL; Lewis DW
    Community Dent Health; 1996 Jun; 13(2):70-5. PubMed ID: 8763135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision analysis for resource allocation in health care.
    Griffin S; Claxton K; Sculpher M
    J Health Serv Res Policy; 2008 Oct; 13 Suppl 3():23-30. PubMed ID: 18806189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty.
    Al MJ; Feenstra TL; Hout BA
    Health Econ; 2005 Jul; 14(7):655-67. PubMed ID: 15678518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of research and value of development in early assessments of new medical technologies.
    Retèl VP; Grutters JP; van Harten WH; Joore MA
    Value Health; 2013; 16(5):720-8. PubMed ID: 23947964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis and policy choices: investing in health systems.
    Murray CJ; Kreuser J; Whang W
    Bull World Health Organ; 1994; 72(4):663-74. PubMed ID: 7923545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic and quality of life outcomes: the four-step pharmacoeconomic research model.
    Arikian SR; Suver J; Einarson T; Doyle J
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):33-6. PubMed ID: 8608054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation in clinical nephrology: Part 1. An introduction to conducting an economic evaluation in clinical practice.
    Wong G; Howard K; Craig JC
    Nephrology (Carlton); 2010 Jun; 15(4):434-40. PubMed ID: 20609095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the limited impact of economic evaluation in health care resource allocation: a conceptual framework.
    Williams I; Bryan S
    Health Policy; 2007 Jan; 80(1):135-43. PubMed ID: 16621124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of diagnostic technology. Methodological challenges and viable solutions.
    Sassi F; McKee M; Roberts JA
    Int J Technol Assess Health Care; 1997; 13(4):613-30. PubMed ID: 9489253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.